Astrazeneca Pharma India Ltd share price logo

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

BSE: 506820

Small Cap

Pharma Sector

₹6733.00

+37.50

(+0.56%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Astrazeneca Pharma India shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+45%

Searches for Astrazeneca Pharma India on INDmoney have increased by 45% over the last 30 days.

Key Events for Astrazeneca Pharma India

Last Dividend Declared

₹36.00 per share, declared on 26/05/2026

View Dividend History

Astrazeneca Pharma India Stock Performance

as on September 16, 2026 at 6:39 pm IST

  • Day's Low

    Day's High

    ₹6,650.50
    ₹6,898.50
    downward going graph

    1.23%

    Downside

    2.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹6,650.50
    ₹9,849.50
    downward going graph

    1.23%

    Downside

    46.29%

    Upside

    downward going graph

Astrazeneca Pharma India share price movements today

Previous Close
₹6,695.50
Open
₹6,696.50
Volume
8,351.00
Upper Circuit
₹8,034.50
Lower Circuit
₹5,356.50
Day's Low - High
₹6,650.50 - ₹6,898.50
52 Week Low - High
₹6,650.50 - ₹9,849.50

Astrazeneca Pharma India Historical Returns

1 Month Return
-12.37 %
3 Month Return
-21.26 %
1 Year Return
-25.74 %
3 Year Return
+ 46.39 %
5 Year Return
+ 112.69 %

Astrazeneca Pharma India Fundamentals

as on September 16, 2026 at 1:09 pm IST

Market Cap

₹16,738.75 Cr

Return on Equity (ROE)

22.82

PE Ratio (TTM)

99.7

Return on capital employed (ROCE)

27.86

Industry PE ratio

51.81

Beta (LTM)

0.5

P/B Ratio

22.23

Dividend Yield

0

PEG Ratio

-15.36

Quarterly Earnings Growth YOY

-32.06

EPS (TTM)

0

Book Value

0

Astrazeneca Pharma India Stock Valuation

as on September 16, 2026 at 1:09 pm IST

Astrazeneca Pharma India in the last 5 years

  • Overview

  • Trends

Lowest (69.69x)

June 30, 2023

Industry (51.81x)

September 11, 2026

Today (99.70x)

September 11, 2026

Highest (236.08x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 99.70x

Astrazeneca Pharma India Technical Analysis

Track how Astrazeneca Pharma India technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Neutral

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish6
Bullish6
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-1.54
Bullish
CCI (20)
-29.9
Neutral
RSI (14)
50.55
Neutral
Momentum (10)
4
Bullish
ADI (14)
33.44
Bearish
Ultimate Oscillator (7,14,28)
31.22
Neutral

Moving Averages

Name

Value

Action

SMA (20)
6726.3
Bearish
EMA (20)
6723.48
Bullish
VWMA (20)
6723.72
Bullish
SMA (50)
6720.92
Bullish
EMA (50)
6735.39
Bearish
SMA (200)
6801.64
Bearish
EMA (200)
6773.83
Bearish
KAMA (200)
6719.77
Bullish
DEMA (200)
6765.77
Bearish

Astrazeneca Pharma India Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Astrazeneca Pharma India with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Astrazeneca Pharma India Ltd image
Astrazeneca Pharma India Ltd
NA16,738.7522.54%0.001872,275
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,206.82-4.25%0.621502,268
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY16,120.3612.3%0.733978,279
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA6,101.01-7.47%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,764.7444.58%0.682811,703
See all

Astrazeneca Pharma India Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
311.07
305.79
383.2
387.52
408
440.29
480.48
526.31
559.09
611.57
578.61
682.79
Other Income
24.8
9.66
8.66
8.35
8.15
7.98
16.15
11.24
6.17
6.61
5.95
9.23
Total Income
335.87
315.45
391.86
395.87
416.15
448.27
496.63
537.55
565.26
618.18
584.56
692.02
Expenses
258.31
290.74
333.81
407.01
355.46
396.85
399.79
445.56
489.2
566.74
518.78
634.09
Operating Profit
52.76
15.05
49.39
-19.49
52.54
43.44
80.69
80.75
69.89
44.83
59.83
48.7
Operating Profit Margin %
16.96%
4.92%
12.89%
-5.03%
12.88%
9.87%
16.79%
15.34%
12.5%
7.33%
10.34%
7.13%
Profit Before Interest, Tax and Depreciation
77.56
24.71
58.05
-11.14
60.69
51.42
96.84
91.99
76.06
51.44
65.78
57.93
Interest
0.5
0.61
-0.07
0.11
0.34
0.33
0.68
0.72
0.67
1.06
2.04
1.95
Depreciation
3.68
3.7
3.76
3.91
9.32
9.07
17.69
16.57
2.57
3.84
5.6
5.23
Profit Before Tax
73.38
20.4
54.36
-15.16
51.03
42.02
78.47
74.7
72.82
46.54
58.14
50.75
Tax Paid
21.01
4.6
14.88
-3.37
12.6
11.17
20.22
18.87
18.6
13.95
13.26
12.82
Profit After Tax
52.37
15.8
39.48
-11.79
38.43
30.85
58.25
55.83
54.22
32.59
44.88
37.93
Total Net profit including share of profit / Loss from associate company
52.37
15.8
39.48
-11.79
38.43
30.85
58.25
55.83
54.22
32.59
44.88
37.93
EPS
20.95
6.32
15.79
-4.72
16.37
12.34
23.3
22.33
21.69
13.04
17.95
15.17
Actual EPS
20.95
6.32
15.79
-4.72
16.37
12.34
23.3
22.33
21.69
13.04
17.95
15.17
Adjusted EPS
20.95
6.32
15.79
-4.72
16.37
12.34
23.3
22.33
21.69
13.04
17.95
15.17
Diluted EPS
20.95
6.32
15.79
-4.72
16.37
12.34
23.3
22.33
21.69
13.04
17.95
15.17

Astrazeneca Pharma India Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
571
728.29
831.81
813.56
805.6
1,002.97
1,295.53
1,716.29
2,275.58
Other Income
12.25
16.29
12.99
12.84
14.76
26.1
51.23
40.63
28.49
Total Income
583.25
744.58
844.8
826.41
820.36
1,029.07
1,346.76
1,756.92
2,304.07
Expenses
524.71
656.99
711.11
678.09
719.43
878.07
1,111.08
1,559.11
2,018.8
Operating Profit
46.29
71.3
120.7
135.47
86.17
124.9
184.45
157.18
256.78
Operating Profit Margin %
8.11%
9.79%
14.51%
16.65%
10.7%
12.45%
14.24%
9.16%
11.28%
Profit Before Interest, Tax and Depreciation
58.54
87.59
133.69
148.31
100.93
151
235.68
197.81
285.27
Interest
-
-
1.14
1.09
0.95
0.63
1.2
1.46
4.49
Depreciation
14.74
14.92
18.58
20.13
16.95
16.26
14.94
39.99
28.58
Profit Before Tax
43.8
72.67
113.97
127.09
83.03
134.11
219.54
156.36
252.2
Tax Paid
17.89
18.22
41.75
33.79
21.44
34.81
58.03
40.62
64.68
Profit After Tax
25.91
54.44
72.22
93.3
61.59
99.29
161.51
115.74
187.52
Total Net profit including share of profit / Loss from associate company
25.91
54.44
72.22
93.3
61.59
99.29
161.51
115.74
187.52
EPS
10.37
21.78
28.89
37.32
24.64
39.72
64.6
46.3
75.01
Actual EPS
10.37
21.78
28.89
37.32
24.64
39.72
64.6
46.3
75.01
Adjusted EPS
10.37
21.78
28.89
37.32
24.64
39.72
64.6
46.3
75.01
Diluted EPS
10.37
21.78
28.89
37.32
24.64
39.72
64.6
46.3
75.01

Astrazeneca Pharma India Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
56.99
38.1
8.79
54.98
87.42
104.78
100.8
58.29
27.87
65.36
-15.14
Cash Flow from Investing Activities
-3.6
0.25
-9.36
4.28
-170.8
173.03
4.74
18.11
21.74
30.8
18.69
Cash Flow from Financing Activities
-0.22
-
-
-
-6.36
-8.97
-9.46
-24.48
-44.38
-65.59
-91.97
Net Cash Flow
52.87
38.35
-0.57
59.26
-89.74
268.84
96.08
51.92
5.23
30.57
-88.42

Astrazeneca Pharma India Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
75%
75%
75%
75%
75%
75%
75%
75%
75%
75%
75%
DII
2.75%
3.78%
5.01%
5.1%
5.22%
4.65%
4.56%
5.26%
5.56%
5.8%
6.08%
FII
0%
2.74%
2.79%
2.9%
2.93%
2.89%
3.03%
2.74%
2.71%
2.78%
2.68%
Public
19.57%
18.48%
17.2%
17%
16.85%
17.46%
17.41%
17%
16.73%
16.42%
16.24%
Total Outstanding Shares
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
2,50,00,000
Total Shareholders
29,032
29,418
27,169
27,615
27,322
32,466
34,378
32,914
31,551
29,007
29,338

Mutual Funds Buying / Exiting Astrazeneca Pharma India

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Astrazeneca Pharma India

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

ICICI Prudential Healthcare Fund Direct Growth

ICICI Prudential Healthcare Fund Direct Growth

₹134.50 Cr

₹35.60 Cr (+35.99%)

1.99%

Bandhan Innovation Fund Direct Growth

Bandhan Innovation Fund Direct Growth

₹73.85 Cr

₹7.19 Cr (+10.79%)

3.36%

Mutual Funds Exiting Astrazeneca Pharma India

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Astrazeneca Pharma India Corporate Actions

View detailed summary of the earnings and dividend history of Astrazeneca Pharma India.

  • Astrazeneca Pharma India Ltd Earnings Results

    Astrazeneca Pharma India Ltd’s net profit fell -32.06% since last year same period to ₹37.93Cr in the Q1 2026-2027. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -15.49% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Astrazeneca Pharma India Ltd Dividends May,2026

    In the quarter ending March 2026, Astrazeneca Pharma India Ltd has declared dividend of ₹36.00 per share on 26 May 2026 - translating a dividend yield of 0.53%.

    Read More about Dividends

Indices Featuring Astrazeneca Pharma India Stock

Check stock indices that include Astrazeneca Pharma India.

BSE Healthcare

₹50,365.35

-113.46 (▲0.22%)

Insights on Astrazeneca Pharma India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 5.66% to 6.01% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 111.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 76.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 75.00% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ASTRAZEN stock has moved down by -12.4%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.78% to 2.68% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 16.42% to 16.24% in Jun 2026 quarter

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited (APIL) was incorporated on the 11th of July 1979 and is a subsidiary of AstraZeneca Pharmaceuticals AB Sweden, which is an indirect subsidiary of AstraZeneca Plc. It is engaged in manufacture, distribution and marketing of pharmaceutical products in therapy areas such as Onocology, Alimentary Metabolism, Cardio Vascular, Renal Diabetes, Respiratory and Oncology. The company suffered a performance setback due to supply stabilization in 2012, following which the current year witnessed series of regulatory interventions in the Indian Pharmaceutical Market covering 348 medicines including 15 SKUs across 8 brands of the company listed on the National List of Essential Medicines (NLEM). During the year, APIL introduced Arimidex, an Oncology product for the management of breast cancer and decided to make its Astrazeneca India’s RD as a part of its global RD organisation. In 2013-14, the market share of drug brand Brilinta (Ticagrelor) which provides cardiologists with a new and effective treatment to help reduce the rate of heart attack and cardiovascular deaths grew from 1.4 MAT March 2013 to 6.7 MAT March 2014. For the FY 2013-14, the company experienced a range of patient price reduction of 452 and an average price reduction of 30. In 2015-16, key growth brands of APIL such as Brilinta, Forxiga, Onglyza, Kombiglyze, Symbicort witnessed robust growth and diabetes portfolio grew by 74 post acquisition from Bristol MyersSquibb. Meanwhile, Meronem became the company’s first brand to cross the Rs. 100 crore sales milestone. The company entered into three Distribution Services Agreements with Dr. Reddy's Laboratories, Sun Pharma for Ticagrelor and Diabetes treatments, while APIL, Dr. Reddy's Laboratories and Sun Pharma copromote market and distributed Saxagliptin, Dapagliflozin and Ticagrelor under different brand names in Indian markets. During 2017-18, the company aligned its portfolio to AstraZeneca's Global therapeutic focus and introduced Xigduo, a fixed dose combination drug to improve glycemic control for type 2 diabetes mellitus. In 2020-21, the company launched Lynparza, Calquence Acalabrutinib and Benralizumab

Revenue: ₹682.79Cr as on June 2026 (Q1 FY27)
Net Profit: ₹37.93Cr as on June 2026 (Q1 FY27)
Listing date: 30 Jul, 1998
Chairperson Name: Narayan K Seshadri
OrganisationAstrazeneca Pharma India Ltd
HeadquartersBangalore
IndustryPharmaceuticals
CEONarayan K Seshadri
E-voting on sharesClick here to vote

FAQs

What is Astrazeneca Pharma India share price today?

Astrazeneca Pharma India share price today stands at ₹6733 as on . Astrazeneca Pharma India share today touched a day high of ₹6898.5 and a low of ₹6650.5.

What is the 52 week high and 52 week low range for Astrazeneca Pharma India share?

Astrazeneca Pharma India touched a 52 week high of ₹9849.5 and a 52 week low of ₹6650.5. Astrazeneca Pharma India share price today i.e. is trending at ₹6733, which is -31.64% down from its 52 week high and 1.24% up from its 52 week low.

What is Astrazeneca Pharma India's market capitalisation today?

Astrazeneca Pharma India market capitalisation is ₹16,738.75 Cr as on .

How to buy Astrazeneca Pharma India shares?

To buy Astrazeneca Pharma India shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ASTRAZEN or Astrazeneca Pharma India Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Astrazeneca Pharma India shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Astrazeneca Pharma India trading volume today?

Astrazeneca Pharma India trading volume is 8,351.00 as on . This means that 8,351.00 shares of Astrazeneca Pharma India were bought and sold on the stock market during today's trading session.